Kohilavani Velayudam
Epilepsy · Duluth, GANPI 1386819381
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 175 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by UCB, Inc. at 33.3% of the total.
Across 175 payments — averaging $18.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- UCB, Inc.$1K
- Sunovion Pharmaceuticals Inc.$345
- Neurelis, Inc.$325
- Jazz Pharmaceuticals Inc.$307
- Catalyst Pharmaceuticals, Inc.$257
- Sumitomo Pharma America, Inc.$149
- plus $806 from 14 others
What the payments were for
- Food & beverage$3,271100%
- Education$130%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| UCB, Inc. | 70 | $1,094 |
| Sunovion Pharmaceuticals Inc. | 29 | $345 |
| Neurelis, Inc. | 12 | $325 |
| Jazz Pharmaceuticals Inc. | 14 | $307 |
| Catalyst Pharmaceuticals, Inc. | 6 | $257 |
| Sumitomo Pharma America, Inc. | 6 | $149 |
| Eisai Inc. | 7 | $143 |
| Supernus Pharmaceuticals, Inc. | 7 | $141 |
| Aquestive Therapeutics, Inc. | 5 | $98 |
| Greenwich Biosciences, Inc. | 4 | $75 |
| Otter Pharmaceuticals, LLC | 2 | $62 |
| Zogenix Inc. | 3 | $58 |
| Acadia Pharmaceuticals Inc | 2 | $44 |
| Upsher-smith Laboratories LLC | 1 | $31 |
| SK Life Science, Inc. | 1 | $29 |
| Biocodex, Inc. | 1 | $27 |
| Teva Pharmaceuticals USA, Inc. | 1 | $26 |
| Azurity Pharmaceuticals, Inc. | 1 | $25 |
| Aucta Pharmaceuticals, Inc. | 2 | $24 |
| Aprecia Pharmaceuticals, LLC | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Fycompa$149
How this compares
Too few epilepsy providers in Georgiato place this figure against a meaningful peer group, so we don't.
Other epilepsy in Duluth
- Ezequiel GleichgerrchtAtlanta$10K
- Rebecca MatthewsAtlanta$7K
- Danielle WeissAugusta$5K
- Katie BullingerAtlanta$4K
- Ekta ShahAtlanta$3K
- Aida RismanAtlanta$2K
- Daniel WinkelAtlanta$706
- Brian CabanissAtlanta$241
- Charles EpsteinAtlanta$158
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.